Audited Financial Results For The Half Year and Year Ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shanmuga Hospital reported revenue from operations of Rs. 4,743.61 Lakhs for FY2026, marginally declining from Rs. 4,785.33 Lakhs in FY2025. Profit After Tax stood at Rs. 421.06 Lakhs, virtually flat compared to Rs. 420.67 Lakhs in the previous year. The company achieved an operating cash flow of Rs. 1,231.42 Lakhs, a significant improvement from negative Rs. 156.94 Lakhs in FY2025. The company spent heavily on capital expenditure (Rs. 2,046.76 Lakhs on PPE), reducing cash reserves from Rs. 1,258.93 Lakhs to Rs. 192.52 Lakhs. Deferred tax liabilities nearly doubled from Rs. 41.35 Lakhs to Rs. 104.92 Lakhs. The statutory auditor issued an unmodified (clean) opinion, and the company voluntarily decided to adopt quarterly reporting despite being listed on BSE SME platform where it is not mandatory.
Revenue remained flat while PAT growth was negligible at 0.09%, indicating limited operational growth. The strong operating cash flow and clean audit are positives, but the heavy capex spending has depleted cash reserves. Shareholders should note the voluntary quarterly reporting adoption signals improved corporate governance.